Arya News - Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev, who is also the Russian special presidential envoy for investment and economic cooperation with foreign countries, believes that European Commission President Ursula von der Leyen is hiding the truth about the EU`s purchase of coronavirus vaccines.
In late June, Financial Times reported that a number of members of the European Parliament were initiating a vote of no confidence in the head of the European Commission due to the scandal surrounding the purchase of coronavirus vaccines during the pandemic. On Monday, a debate on a vote of no confidence in the head of the European Commission was held at the plenary session of the EP in Strasbourg. The vote on this issue will take place on Thursday. Earlier, media reported that the entire European Commission would be forced to resign if a vote of no confidence was passed against von der Leyen. It was noted that at this stage, the vote was mainly "symbolic" in nature, since the majority of EU parliamentarians had already made it clear that they would not support the vote of no confidence. At the same time, the initiative with the vote itself, according to media reports, underscores the growing dissatisfaction with von der Leyen in Brussels after a series of "contradictory actions and scandals." The EU Court of Justice in Luxembourg previously ruled that the European Commission had committed violations in the procurement of coronavirus vaccines in 2020 and 2021 by blocking public access to information on drug prices, and also failing to prove the absence of a conflict of interest in making such purchases. In 2021, the New York Times reported that von der Leyen and Pfizer CEO Albert Bourla discussed the largest vaccine purchase contract in the history of the European Union in a text message exchange. Von der Leyen was already suspected of directly influencing the negotiation process; the scandal in the media was called "Pfizergate." The total value of the deal could have reached 35 billion euros, and the 1.8 billion doses purchased significantly exceeded the needs of EU residents. Von der Leyen was called for the contents of the correspondence to be published, but the European Commission refused to make it public in June 2022.